Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)

Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL) / Ferreri, A.j., Dell'Oro, S., Foppoli, M., Brandes, A.a., Montanari, M., Balzarotti, M., Spina, M., Ilariucci, F., Zaja, F., Reni, M.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 23:16(2005), pp. 121S-121S.